Discontinuation report VAN-SERTRALINE
Report ID | 58507 |
Drug Identification Number | 02427796 |
Brand name | VAN-SERTRALINE |
Common or Proper name | SERTRALINE (SERTRALINE HYDROCHLORIDE) |
Company Name | VANC PHARMACEUTICALS INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | SERTRALINE |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2017-02-28 |
Remaining supply date | 2017-02-28 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2639 VIKING WAY, UNIT 210 RICHMOND, BRITISH COLUMBIA CANADA V6V 3B7 |
Company contact information | info@vancpharm.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-08-17 | English | Compare |
v2 | 2018-08-17 | French | Compare |
Showing 1 to 2 of 2